VERTEX PHARMACEUTICALS INC / MA Quarterly Common Stock, Shares, Issued from Q1 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Vertex Pharmaceuticals Inc / Ma quarterly Common Stock, Shares, Issued history and growth rate from Q1 2010 to Q2 2024.
  • Vertex Pharmaceuticals Inc / Ma Common Stock, Shares, Issued for the quarter ending June 30, 2024 was 258M shares, a 0.09% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 258M +223K +0.09% Jun 30, 2024 10-Q 2024-08-02
Q1 2024 258M +786K +0.31% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 258M +684K +0.27% Dec 31, 2023 10-Q 2024-08-02
Q3 2023 258M +1.18M +0.46% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 258M +1.77M +0.69% Jun 30, 2023 10-Q 2023-08-02
Q1 2023 258M +1.93M +0.76% Mar 31, 2023 10-Q 2023-05-02
Q4 2022 257M +2.53M +1% Dec 31, 2022 10-K 2024-02-15
Q3 2022 257M +440K +0.17% Sep 30, 2022 10-Q 2022-10-28
Q2 2022 256M -3.09M -1.19% Jun 30, 2022 10-Q 2022-08-05
Q1 2022 256M -3.25M -1.26% Mar 31, 2022 10-Q 2022-05-06
Q4 2021 254M -5.41M -2.08% Dec 31, 2021 10-K 2023-02-10
Q3 2021 256M -3.97M -1.53% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 259M -1.01M -0.39% Jun 30, 2021 10-Q 2021-07-30
Q1 2021 259M -250K -0.1% Mar 31, 2021 10-Q 2021-04-30
Q4 2020 260M +897K +0.35% Dec 31, 2020 10-K 2022-02-09
Q3 2020 260M +2.91M +1.13% Sep 30, 2020 10-Q 2020-10-30
Q2 2020 260M +3.45M +1.35% Jun 30, 2020 10-Q 2020-07-31
Q1 2020 259M +2.73M +1.06% Mar 31, 2020 10-Q 2020-05-01
Q4 2019 259M +3.82M +1.5% Dec 31, 2019 10-K 2021-02-11
Q3 2019 257M +1.65M +0.65% Sep 30, 2019 10-Q 2019-10-31
Q2 2019 257M +1.79M +0.7% Jun 30, 2019 10-Q 2019-08-01
Q1 2019 256M +1.42M +0.56% Mar 31, 2019 10-Q 2019-05-01
Q4 2018 255M +1.92M +0.76% Dec 31, 2018 10-K 2020-02-13
Q3 2018 256M +2.93M +1.16% Sep 30, 2018 10-Q 2018-10-25
Q2 2018 255M +4.11M +1.64% Jun 30, 2018 10-Q 2018-07-26
Q1 2018 255M +6.04M +2.43% Mar 31, 2018 10-Q 2018-04-27
Q4 2017 253M +4.95M +2% Dec 31, 2017 10-K 2019-02-13
Q3 2017 253M +4.65M +1.88% Sep 30, 2017 10-Q 2017-10-30
Q2 2017 251M +3.07M +1.24% Jun 30, 2017 10-Q 2017-07-28
Q1 2017 249M +1.6M +0.65% Mar 31, 2017 10-Q 2017-04-28
Q4 2016 248M +1.99M +0.81% Dec 31, 2016 10-K 2018-02-15
Q3 2016 248M +2.38M +0.97% Sep 30, 2016 10-Q 2016-10-31
Q2 2016 248M +3.36M +1.38% Jun 30, 2016 10-Q 2016-08-01
Q1 2016 247M +3.71M +1.52% Mar 31, 2016 10-Q 2016-05-03
Q4 2015 246M +4.54M +1.88% Dec 31, 2015 10-K 2017-02-23
Q3 2015 246M +5.41M +2.25% Sep 30, 2015 10-Q 2015-10-30
Q2 2015 244M +7.01M +2.95% Jun 30, 2015 10-Q 2015-08-04
Q1 2015 244M +7.38M +3.12% Mar 31, 2015 10-Q 2015-05-04
Q4 2014 242M +7.98M +3.41% Dec 31, 2014 10-K 2016-02-16
Q3 2014 240M +6.65M +2.85% Sep 30, 2014 10-Q 2014-11-06
Q2 2014 237M Jun 30, 2014 10-Q 2014-07-31
Q1 2014 236M +17.5M +8.03% Mar 31, 2014 10-Q 2014-05-05
Q4 2013 234M +16.5M +7.6% Dec 31, 2013 10-K 2015-02-13
Q3 2013 234M +17.3M +7.97% Sep 30, 2013 10-Q 2013-11-07
Q1 2013 219M +7.79M +3.69% Mar 31, 2013 10-Q 2013-05-08
Q4 2012 217M +7.98M +3.81% Dec 31, 2012 10-K 2014-02-11
Q3 2012 216M +7.88M +3.78% Sep 30, 2012 10-Q 2012-11-06
Q2 2012 215M +7.96M +3.84% Jun 30, 2012 10-Q 2012-08-08
Q1 2012 211M +5.41M +2.63% Mar 31, 2012 10-Q 2012-05-10
Q4 2011 209M +5.78M +2.84% Dec 31, 2011 10-K 2013-03-01
Q3 2011 208M +5.36M +2.64% Sep 30, 2011 10-Q 2011-11-03
Q2 2011 207M +4.94M +2.44% Jun 30, 2011 10-Q 2011-08-09
Q1 2011 205M +3.34M +1.65% Mar 31, 2011 10-Q 2011-05-06
Q4 2010 204M Dec 31, 2010 10-K 2012-02-22
Q3 2010 203M Sep 30, 2010 10-Q 2010-10-28
Q2 2010 203M Jun 30, 2010 10-Q 2010-08-03
Q1 2010 202M Mar 31, 2010 10-Q 2010-05-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.